Literature DB >> 225353

Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system.

R A Clark, S J Klebanoff.   

Abstract

Polymorphonuclear leukocytes may modulate the acute inflammatory response by the secretion of enzymes capable of inactivating mediators of inflammation. The ability of the myeloperoxidase-H(2)O(2)-halide system of the neutrophil to inactivate chemoattractants was examined using both a radioassay and a morphologic assay of chemotaxis. Incubation of either a complement-derived agent, C5a, or a synthetic formyl-methionyl peptide chemoattractant with the myeloperoxidase system for 15 min at 37 degrees C resulted in essentially complete loss of chemotactic activity. Inactivation was dependent on enzymatically active myeloperoxidase, H(2)O(2) or a peroxide-generating enzyme system, and a halide cofactor. It was blocked by agents which inhibit peroxidase (azide) or degrade H(2)O(2) (catalase). Inactivation of chemoattractants was time-dependent, reaching maximal levels within 1-5 min, and temperature-dependent with no significant inactivation occurring at 0 degrees C. H(2)O(2) alone had no significant inactivating ability at concentrations as high as 10 mM, whereas in the presence of myeloperoxidase and a halide, 0.1 muM H(2)O(2) showed significant activity and 10 muM H(2)O(2) caused complete inactivation. On a molar basis, the order of effectiveness of the halide cofactors was Br(-) > I(-) > Cl(-), although only chloride was fully active at physiologic concentrations. Neutrophils stimulated by phagocytosis or by membraneperturbing agents secrete enzymatic constituents, including myeloperoxidase, and metabolic products such as H(2)O(2). Thus, it is suggested that the myeloperoxidase system acting at an extracellular site serves as an inflammatory control mechanism by virtue of its ability to inactivate neutrophil chemoattractants.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225353      PMCID: PMC372199          DOI: 10.1172/JCI109557

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  A functional differentiation of human neutrophil granules: generation of C5a by a specific (secondary) granule product and inactivation of C5a by azurophil (primary) granule products.

Authors:  D G Wright; J I Gallin
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

2.  Role of the myeloperoxidase-H2O2-halide system in concanavalin A-induced tumor cell killing by human neutrophils.

Authors:  R A Clark; S J Klebanoff
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

3.  Oxygen-dependent microbial killing by phagocytes (second of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-30       Impact factor: 91.245

4.  Myeloperoxidase-mediated platelet release reaction.

Authors:  R A Clark; S J Klebanoff
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

5.  Chemotactic factor inactivators of human granulocytes.

Authors:  J P Brozna; R M Senior; D L Kreutzer; P A Ward
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

6.  Mast cell granule peroxidase: location, secretion, and SRS-A inactivation.

Authors:  W R Henderson; M Kaliner
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

7.  In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes.

Authors:  H Carp; A Janoff
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

8.  Role of secretory events in modulating human neutrophil chemotaxis.

Authors:  J I Gallin; D G Wright; E Schiffmann
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

9.  Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.

Authors:  H N Fernandez; T E Hugli
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

10.  Myeloperoxidase--H2O2--halide system: cytotoxic effect on human blood leukocytes.

Authors:  R A Clark; S J Klebanoff
Journal:  Blood       Date:  1977-07       Impact factor: 22.113

View more
  32 in total

1.  Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase.

Authors:  O I Aruoma; B Halliwell
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

2.  Acquisition of peroxidase activity by rat alveolar macrophages during pulmonary inflammation.

Authors:  J Shellito; M Sniezek; M Warnock
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

3.  Oxidative inactivation of Actinobacillus actinomycetemcomitans leukotoxin by the neutrophil myeloperoxidase system.

Authors:  R A Clark; K G Leidal; N S Taichman
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

4.  Generation and characterization of a neutrophil-derived inhibitor of fibroblast chemotaxis.

Authors:  H Mensing; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

Review 5.  Myeloperoxidase in human neutrophil host defence.

Authors:  William M Nauseef
Journal:  Cell Microbiol       Date:  2014-06-19       Impact factor: 3.715

6.  Seaweed natural products modify the host inflammatory response via Nrf2 signaling and alter colon microbiota composition and gene expression.

Authors:  Michelle S Bousquet; Ranjala Ratnayake; Jillian L Pope; Qi-Yin Chen; Fanchao Zhu; Sixue Chen; Thomas J Carney; Raad Z Gharaibeh; Christian Jobin; Valerie J Paul; Hendrik Luesch
Journal:  Free Radic Biol Med       Date:  2019-09-16       Impact factor: 7.376

Review 7.  Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system.

Authors:  W M Nauseef
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

8.  Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient.

Authors:  O Stendahl; B I Coble; C Dahlgren; J Hed; L Molin
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

9.  Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro.

Authors:  H Carp; A Janoff
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

Review 10.  Hematopoetic stem cell transplantation in neutrophil disorders: severe congenital neutropenia, leukocyte adhesion deficiency and chronic granulomatous disease.

Authors:  Ronit Elhasid; Jacob M Rowe
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.